Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds
BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness
CDC Warns of E. Coli Outbreak Linked to Baby Spinach
Illness reported in Indiana, Iowa, Michigan, Minnesota, Missouri, Ohio, South Dakota; two hospitalizations but no deaths reported
Salmonella Outbreak Linked to Salami Sticks Rises to 31 Cases in 10 States
There have been six hospitalizations reported, but no deaths
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated
Prior infection linked to lower risk for breakthrough infection among individuals vaccinated with BNT162b2 or mRNA-1273
Federal Court Backs Stay on COVID-19 Vaccine Mandate for Large Businesses
Legal challenges against the mandate have been filed by at least 27 states in at least six federal appeals courts
More Than 2 Million COVID-19 Home Test Kits Recalled Due to False-Positive Results
35 reports of false-positive results sent to the FDA, but no deaths have been reported
Therapeutic Heparin May Benefit Moderately Ill COVID-19 Inpatients
Among those with increased D-dimer levels, no reduction seen in primary composite outcome at 28 days, but odds of death decreased
